This paper investigated the effects of storage with or without EDTA for up to 7 days at room temperature or 4°C and up to five freeze-thaw cycles on levels of calprotectin in synovial fluid. Additionally, the effects of specimen dilution with hemolyzed blood, non-hemolyzed blood, or lipids (adipocyte lysate, intralipid or chylomicrons) on the quantified levels of calprotectin were investigated. Effects of freeze-thaw cycling, enzymatic treatment (hyaluronidase and/or DNase) and sonification on synovial fluid viscosity and calprotectin levels were also investigated.
(Pre)analytical considerations concerning the analysis of synovial calprotectin.
Alkadhem MF, Wagenmakers-Huizenga LMF, Wouthuyzen-Bakker M, Muller Kobold AC
Purpose
Conclusion
Calprotectin levels were not significantly affected by storage of synovial fluid at room temperature or 4°C for up to 7 days regardless of the inclusion of EDTA, or up to five freeze-thaw cycles in the absence of EDTA, but calprotectin levels were higher in synovial fluid collected in EDTA tubes that underwent one or two freeze-thaw cycles (but not ≥3) than those not freeze-thaw cycled. Calprotectin levels were not consistently affected by the addition of hemolyzed or non-hemolyzed blood, or lipids (adipocyte lysate, intralipid or chylomicrons) to synovial fluid specimens.
The authors report that synovial fluid viscosity was unaffected by five freeze-thaw cycles. Synovial fluid viscosity decreased with hyaluronidase and/or DNase treatment, but calprotectin levels were not significantly affected. In contrast, viscosity was reduced and calprotectin levels were significantly increased after sonification.
Studies (1)
Purpose
This study investigated the effects of storage with or without EDTA for up to 7 days at room temperature or 4°C and up to five freeze-thaw cycles on levels of calprotectin in synovial fluid. Additionally, the effects of specimen dilution with hemolyzed blood, non-hemolyzed blood, or lipids (adipocyte lysate, intralipid or chylomicrons) on the quantified levels of calprotectin were investigated. Effects of freeze-thaw cycling, enzymatic treatment (hyaluronidase and/or DNase) and sonification on synovial fluid viscosity and calprotectin levels were also investigated. Synovial fluid was collected from patients (diagnosis not provided) into 20 mL syringes using a 21-gauge needle and analyzed immediately. Residual specimens were stored at -80°C until three specimens could be selected for each storage and contamination experiment so that low (20–40 mg/L), medium (40–100 mg/L) and high (100–200 mg/L) levels of calprotectin were represented in each experiment. To test the effect of EDTA on calprotectin stability, three selected specimens were aspirated into EDTA and plain tubes and stored at room temperature for 0 h, 3 h, 6 h, 24 h, 3 days and 7 days; at 4°C for 6 h, 24 h, 3 days and 7 days; or subjected to 1, 2, 3, or 5 freeze-thaw cycles (details not provided) before reanalysis. To investigate the effects of blood and lipid contamination, aliquots of the three synovial specimens were mixed with hemolyzed blood (obtained by three freeze-thaw cycles), non-hemolyzed blood, adipocyte homogenate, intralipid or chylomicrons to achieve contaminant concentrations of 50%, 25%, 12.5%, 6.25%, 3.12%, 1.56%, 0.76%, 0.38% and 0%. To determine the incidence of hemolysis and lipemia in synovial specimens, data for 83 synovial specimens from 74 patients were surveyed for the hemolytic index (H-index) and the lipemic index (L-index). Hemolysis and lipemic indices were measured using a Cobas 6000 chemistry analyzer. To investigate the effects of viscosity on the measurement of calprotectin, three synovial fluid specimens (68, 85 and 136 mg/L calprotectin) were subjected to five freeze-thaw cycles and then a single treatment with hyaluronidase, DNase or both hyaluronidase and DNase for 30 min at 37°C before quantification of calprotectin. Additionally, to measure the effects of viscosity, 25 freshly collected synovial fluid specimens were analyzed before and after sonification for 10 s with a Vibra cell, model VC60 sonificator. Calprotectin levels were quantified using the Lyfstone rapid LF test.
Summary of Findings
Calprotectin levels were unaffected by storage of synovial fluid at room temperature or 4°C for up to 7 days, regardless of the inclusion of EDTA; however, after 7 days, there was a trend toward lower calprotectin levels in specimens stored with EDTA than without. Calprotectin levels were higher in synovial fluid in EDTA tubes that underwent one or two freeze-thaw cycles than those not freeze-thaw cycled (P=0.011 and P=0.003), but there was no difference in calprotectin levels between EDTA specimens freeze-thaw cycled ≥3 times and those not freeze-thaw cycled; and there was no effect of up to five freeze-thaw cycles on calprotectin levels in synovial fluid in tubes without EDTA. While at some dilutions the addition of hemolyzed blood appeared to decrease the quantity of calprotectin, the effect was not consistent in specimens with the lowest calprotectin levels that contained 1.56% hemolyzed blood or in specimens with the highest calprotectin levels that contained 12.5% hemolyzed blood. Calprotectin levels were generally higher when non-hemolyzed blood was added than when hemolyzed blood was added, but (similar to hemolyzed blood) no consistent effect was observed. There was no effect associated with the addition of lipids (adipocyte lysate, intralipid or chylomicrons) to synovial specimens on the quantified levels of calprotectin.
The authors report that synovial fluid viscosity was unaffected by five freeze-thaw cycles. Synovial fluid viscosity decreased with hyaluronidase and or DNase treatment, but calprotectin levels were not significantly affected. In contrast, synovial fluid viscosity was reduced and calprotectin levels were significantly higher after sonification (100.5 mg/L after versus 59 mg/L before, P<0.01).
Biospecimens
FluidSynovial FluidPreservation Types
FrozenNone (Fresh)Diagnoses
Not specifiedPlatforms
ProteinImmunoassayProteinClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Biospecimen components 0-50% adipocyte lysate0-50% chylomicron0-50% hemolyzed blood0-50% intralipid0-50% non-hemoylzed bloodBiospecimen Preservation Type of fixation/preservation EDTANone (fresh)Storage Freeze/thaw cycling 1 cycle2 cycles3 cycles4 cycles5 cyclesStorage Short-term storage solution EDTANoneStorage Storage duration 3 d6 h7 dStorage Storage temperature 4°CRoom temperatureStorage Time at room temperature 0 h24 h3 d3 h6 h7 dAnalyte Extraction and Purification Cell/tissue permeabilization 5 freeze-thaw cyclesDNase and hyaluronidase treatedDNase treatedHyaluronidase treatedSonification